Open Nav

Aktivax, Inc

Show how next generation auto-injector developed under DoD contracts applies to private markets

  • Date:Thursday, October 18
  • Time:3:00 PM - 3:15 PM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Aktivax is a specialty pharmaceutical company developing products utilizing a novel single use auto injector platform called ARAI. We design and develop drug delivery technologies for both defense and consumer emergency treatment applications. Our mission is "Delivering Peace-of-Mind"
  • Company
  • Company HQ City:Broomfield, CO
  • Company HQ Country:United States
  • Company HQ State:Colorado                   
  • CEO/Top Company Official:Amir Genosar
  • Year Founded:20
  • Main Therapeutic Focus:Medical Devices
  • Lead Product in Development :ARAI Auto-Injector
  • Development Phase of Primary Product:Discovery
  • Number Of Unlicensed Products (For Which You Are Seeking Partners) :1
  • Additional Information/Comments:Aktiva is leveraging a $55M BARDA contract and several DoD contracts to advance private market auto-injector products to commercialization. The ARAI auto-injector has not only Defense and Security application for Medical Counter Measures against chemical attacks, but also can deliver opioid overdose reversal, epinephrine and other emergency treatments that require a single step reliable treatment in a durable delivery method.
  • Previous and Current Investors:High Country Ventures,
  • Size of Last Investment Round:n/a
  • Total Amount Raised to Date, In All Rounds:$1M